M Helle

905 total citations
30 papers, 676 citations indexed

About

M Helle is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, M Helle has authored 30 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in M Helle's work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Estrogen and related hormone effects (7 papers). M Helle is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Estrogen and related hormone effects (7 papers). M Helle collaborates with scholars based in Finland, Bahrain and Japan. M Helle's co-authors include Jorma Isola, Heikki J. Helin, Olli Kallioniemi, Kai Krohn, Heikki Helin, Ullamari Hakulinen, J. M. Koski, Heikki Hermunen, Simo Saarakkala and Tapani Liukkonen and has published in prestigious journals such as Cancer, The Journal of Urology and British Journal of Cancer.

In The Last Decade

M Helle

30 papers receiving 644 citations

Peers

M Helle

ONCOL

PFM

SURGE

H Pickartz Germany

Toni M. Robinson-Smith United States

Maja Nielsen Denmark

A-L Børresen Norway

Rochelle A. Simon United States

K Lauslahti Finland

Patrick Muraca United States

Greg A. Miller United States

Gerard J. Oakley United States

Mary Ann Perle United States

H Pickartz Germany

M Helle

181 ×0.7

ONCOL

149 ×0.7

157 ×0.8

97 ×0.7

PFM

193 ×1.4

SURGE

Citations per year, relative to M Helle M Helle (= 1×) peers H Pickartz

Countries citing papers authored by M Helle

Since Specialization

Citations

This map shows the geographic impact of M Helle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Helle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Helle more than expected).

Fields of papers citing papers by M Helle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Helle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Helle. The network helps show where M Helle may publish in the future.

Co-authorship network of co-authors of M Helle

This figure shows the co-authorship network connecting the top 25 collaborators of M Helle. A scholar is included among the top collaborators of M Helle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Helle. M Helle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlsson, Eva, Annamari Ranki, Leena Karenko, et al.. (2011). Potential role of a navigator gene NAV3 in colorectal cancer. British Journal of Cancer. 106(3). 517–524. 27 indexed citations

Purhonen, Anna‐Kaisa, et al.. (2010). Cryoglobulinaemia and rapidly deteriorating renal function in chronic lymphocytic leukaemia. Nephrology Dialysis Transplantation. 26(3). 1101–1103. 3 indexed citations

Paajanen, Hannu, et al.. (2006). Feasibility of Axillary Ultrasound in the Quality Assessment of Sentinel Node Biopsy in Breast Cancer Surgery. Scandinavian Journal of Surgery. 95(3). 195–198. 5 indexed citations

Koski, J. M., et al.. (2006). Power Doppler ultrasonography and synovitis: correlating ultrasound imaging with histopathological findings and evaluating the performance of ultrasound equipments. Annals of the Rheumatic Diseases. 65(12). 1590–1595. 100 indexed citations

Rajala, Pertti, Tapani Liukkonen, Mika Raitanen, et al.. (1999). TRANSURETHRAL RESECTION WITH PERIOPERATIVE INSTILLATION OF INTERFERON-alpha OR EPIRUBICIN FOR THE PROPHYLAXIS OF RECURRENT PRIMARY SUPERFICIAL BLADDER CANCER: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY-FINNBLADDER III. The Journal of Urology. 161(4). 1133–1136. 44 indexed citations

Liukkonen, Tapani, et al.. (1997). Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Urological Research. 25(1). 1–8. 27 indexed citations

Liukkonen, Tapani, P. Lipponen, M Helle, et al.. (1996). Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in suerficial bladder cancer. Urological Research. 24(1). 61–66. 7 indexed citations

Helle, M, et al.. (1992). The expression of CEA and HMFG antigens in ovarian clear-cell and endomemetroid carcinomas. Pathology - Research and Practice. 188(1-2). 74–77. 6 indexed citations

Isola, Jorma, Heikki J. Helin, M Helle, & Olli Kallioniemi. (1990). Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer. 65(5). 1180–1184. 150 indexed citations

10.

Isola, Jorma, Olli Kallioniemi, Torsten Wahlström, et al.. (1990). Steroid receptors and Ki‐67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival. The Journal of Pathology. 162(4). 295–301. 59 indexed citations

11.

Helin, Heikki J., M Helle, Olli Kallioniemi, & Jorma Isola. (1990). Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry. Cancer. 63(9). 1761–1767. 71 indexed citations

12.

Helin, Heikki, Jorma Isola, M Helle, & T. Koivula. (1990). Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma. British Journal of Cancer. 62(1). 109–112. 16 indexed citations

13.

Helle, M, et al.. (1990). Sudden Death as Sole Symptom of Coronary Arteritis. Annals of Medicine. 22(3). 161–162. 11 indexed citations

14.

Isola, Jorma, M Helle, & Heikki J. Helin. (1990). Immunocytochemical Detection of Progesterone Receptor in Breast Carcinoma: Comparison of Two Monoclonal Antibodies. American Journal of Clinical Pathology. 93(3). 378–382. 6 indexed citations

15.

Helle, M, et al.. (1989). Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters. Journal of Cancer Research and Clinical Oncology. 115(4). 361–365. 7 indexed citations

16.

Helle, M, Heikki Helin, Jaakko Antonen, & Kai Krohn. (1988). Human milk fat globule antigen III D 5, steroid receptors and histopathologic parameters in breast cancer. Apmis. 96(1-6). 415–420. 5 indexed citations

17.

Helle, M, Heikki Helin, J Isola, & Kai Krohn. (1988). Oestrogen receptor content and cancer cell/stroma ratio in mammary carcinoma. Apmis. 96(7-12). 1140–1142. 1 indexed citations

18.

Helin, Heikki J., Jorma Isola, M Helle, & Herman Adlercreutz. (1988). Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients. Breast Cancer Research and Treatment. 12(1). 67–73. 8 indexed citations

19.

Helle, M, et al.. (1986). Monoclonal antibodies are useful in histopathological diagnosis of ovarian tumors. Scandinavian Journal of Immunology. 24(4). 465. 2 indexed citations

20.

Krohn, Kai & M Helle. (1986). Recognition with a monoclonal antibody of a cytoplasmic mammary carcinoma antigen, correlated to the estrogen receptor status. International Journal of Cancer. 37(1). 43–47. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact